Back to search

Massachusetts Institute of Technology

The pharmaco-economics of combination therapies : a study of the effects of component and market factors on combined therapy price

Abstract

dc:description.abstract

For a growing number of indications, combination therapies are becoming increasingly common due in part to their superior efficacy, as compared to monotherapies. In fact, in the case of infectious diseases such as AIDS and tuberculosis, combination therapies are now the standard of care. With the emergence of drug-device combinations, genetic testing, and individualized medicine, this trend towards combination therapies is likely to continue to grow. In this context the pricing of combination therapies is a critical component that needs to be understood by medical practitioners, payors and policy makers. There are three factors to consider in the pricing of combination therapies: the characteristics and structure of the market in which the combined product is sold, the absence or presence of market exclusivity, and the prices of the components of the combined product, when sold individually. When one or more of the components of the combined product has market exclusivity, additional factors such as exclusionary bundling, tying, and double marginalization may come into play.

Degree

thesis:*
Department dc:contributor.department
Harvard University--MIT Division of Health Sciences and Technology.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2006

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Subramaniam, Sundar
Advisor dc:contributor.advisor
  • Frank Douglas.

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/35555
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/35555

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Subramaniam, Sundar. The pharmaco-economics of combination therapies : a study of the effects of component and market factors on combined therapy price. Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/35555